Zura Bio Limited
ZURA
$1.99
$0.2413.71%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 37.92M | 34.78M | 30.79M | 28.20M | 21.14M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 72.37M | 66.06M | 55.19M | 50.28M | 41.15M |
| Operating Income | -72.37M | -66.06M | -55.19M | -50.28M | -41.15M |
| Income Before Tax | -67.76M | -62.10M | -52.40M | -47.25M | -34.82M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -67.76 | -62.10 | -52.40 | -47.25 | -34.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 0.00 | 0.00 |
| Net Income | -67.76M | -62.10M | -52.40M | -47.25M | -34.82M |
| EBIT | -72.37M | -66.06M | -55.19M | -50.28M | -41.15M |
| EBITDA | -72.34M | -66.05M | -46.80M | -31.07M | -11.76M |
| EPS Basic | -0.72 | -0.72 | -0.55 | -0.58 | -0.49 |
| Normalized Basic EPS | -0.47 | -0.45 | -0.43 | -0.45 | -0.41 |
| EPS Diluted | -0.72 | -0.72 | -0.55 | -0.58 | -0.49 |
| Normalized Diluted EPS | -0.47 | -0.45 | -0.43 | -0.45 | -0.41 |
| Average Basic Shares Outstanding | 365.54M | 346.19M | 300.15M | 256.25M | 215.79M |
| Average Diluted Shares Outstanding | 365.54M | 346.19M | 300.15M | 256.25M | 215.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |